Abstract | BACKGROUND: AIM OF THE STUDY: To evaluate the efficacy and tolerability of TPM monotherapy in FLE. METHODS: The study group consisted of 55 (33 male; 22 female) patients. TPM was administered as a first drug (n = 16) or converted after previous treatment (n = 39). All patients were followed every 3 months for at least 1 year. The patients were subdivided into two groups: 'newly diagnosed' patients and 'difficult-to-treat' patients. RESULTS: Overall, all patients completed the 1-year study. At the end of follow-up, 10 patients showed disappearance of seizures and 33 patients showed improvement in seizure frequency. In particular, among the newly diagnosed patients 6/16 patients showed complete cessation of seizures and 5/16 patients showed very good response; in the other group, 4/39 patients showed complete cessation and 4/39 patients showed a very good response. No patients of both groups had worsening of seizures. No treatment-limiting adverse events associated with TPM were reported. CONCLUSIONS: TPM is effective in newly diagnosed patients with FLE; TPM can be considered for the treatment of FLE.
|
Authors | A Verrotti, V Sofia, E Franzoni, G Coppola, R Manco, G L Ciambra, S Savasta, F Chiarelli, P Iannetti |
Journal | Acta neurologica Scandinavica
(Acta Neurol Scand)
Vol. 115
Issue 2
Pg. 132-5
(Feb 2007)
ISSN: 0001-6314 [Print] Denmark |
PMID | 17212619
(Publication Type: Journal Article, Multicenter Study)
|
Chemical References |
- Anticonvulsants
- Topiramate
- Fructose
|
Topics |
- Adolescent
- Adult
- Anticonvulsants
(adverse effects, therapeutic use)
- Child
- Child, Preschool
- Epilepsy, Frontal Lobe
(drug therapy)
- Female
- Follow-Up Studies
- Fructose
(adverse effects, analogs & derivatives, therapeutic use)
- Humans
- Infant
- Male
- Middle Aged
- Patient Compliance
- Retrospective Studies
- Topiramate
- Treatment Outcome
|